“More than a year after the Food and Drug Administration announced it had strengthened its drug safety system, the agency still lacks a reliable system for keeping track of emerging problems, congressional investigators concluded in a report to be released today.” [Los Angeles Times, below]
Three reports illustrate the wide and deepening disconnect between medicine under the influence of pharmaceutical industry marketing goals and scientific evidence that contradicts current practice and public health policies:
APA "Diagnostic Statistical Manual" Task Force has been shown to have financial relationships with drug manufacturers.
Dr. Robert Spitzer, who has continued to play a central role in DSM revisions since 1980, claim he does not think a conflict of interest exists.
See list of APA Task Force on DSM-IV and DSM-IV Revised Text at: https://ahrp.org/cms/content/view/145/27/
The undisclosed financial relationships between drug manufacturers and psychiatry’s leading "authorities" who determine what constitutes a “mental disorder” have been exposed.
The Tacoma Tribune reports that the head of the Center for Disease Control, Dr. Julie Gerberding, has reversed the agency’s bird flu policy, which viewed the threat from the worse-case scenario lens.
The APRIL 7, 2006 issue of SCIENCE Magazine contains one of the most important articles that tackles research fraud.
"Top Republicans — Senate Majority Leader Bill Frist, R-Tenn., and House Speaker Dennis Hastert, R-Ill– recently sold the future of our children to Big Pharma for a paltry $4 bucks a pop."
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
"Risks of anaphylaxis applies to all studies at PAREXEL, with drugs at every stage of development, and the staff are well trained in anticipation of this (unlikely) possibility.
A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.
